Last reviewed · How we verify
NCT04841473
The TRAIN Study: A Concussion Prevention Strategy in Middle Schools
NA trial testing TRAIN Concussion Education in Concussion, Brain in 103 participants. Completed in 30 October 2021.
15 October 2021
Quick facts
| Lead sponsor | University of North Carolina, Chapel Hill |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 103 |
| Start date | 17 May 2021 |
| Primary completion | 15 October 2021 |
| Estimated completion | 30 October 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- TRAIN Concussion Education
- Standard Concussion Education
Conditions studied
- Concussion, Brain — all drugs for Concussion, Brain →
Sponsor
University of North Carolina, Chapel Hill
Who can join
18 and older, any sex, with Concussion, Brain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Purpose: The purpose of this study is to evaluate the effectiveness of a theory-driven intervention (TRAIN concussion education) to improve parental concussion-related attitudes, beliefs, intentions, confidence in knowledge, and self-efficacy. Participants: 180 parents of United States middle school aged children whose children have been engaged in organized sports within the past 2 years. Procedures: The study is a single-blind (participants) randomized control trial. The investigators will randomize eligible parents into two groups: (1) control (standard concussion education); and treatment (standard concussion education AND TRAIN concussion education) to evaluate the effectiveness of the TRAIN concussion education intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An initial assessment of an opinion leader-informed intervention to improve concussion-related outcomes among middle school parents: a randomized controlled trial.
Kerr ZY, Ingram BM, Livingston S, Gildner P, et al · · 2024 · cited 3× · PMID 39183448 · DOI 10.1080/07853890.2024.2393760
Verify or expand the search:
- PubMed search for NCT04841473
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Concussion, Brain
Currently open trials in the same condition.
- NCT06956417 — REhabilitation of MEMory Symptoms After BRain Concussion · NA · recruiting
- NCT06739785 — Turkish Translation of SportsConcussion Assesment Tool 6 · active not recruiting
- NCT06270290 — The COSP-RBD Study: Concussions and Contact Sports in RBD vs Controls · recruiting
- NCT06208813 — Creatine Supplementation in Concussion Recovery · NA · recruiting
- NCT06036147 — Concussion Health Improvement Program · NA · recruiting
Other University of North Carolina, Chapel Hill trials
Trials by the same sponsor.
- NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
- NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
- NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
- NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
- NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04841473 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
- Last refreshed: 15 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04841473.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing